Blackadar C - Search Results

1

Biodistribution of Native and Nanoformulated Innate Defense Regulator Peptide 1002.

Esposito TVF, Blackadar C, Wu L, Rodríguez-Rodríguez C, Haney EF, Pletzer D, Saatchi K, Hancock REW, Häfeli UO. Esposito TVF, et al. Among authors: blackadar c. Mol Pharm. 2024 Jun 3;21(6):2751-2766. doi: 10.1021/acs.molpharmaceut.3c01169. Epub 2024 May 1. Mol Pharm. 2024. PMID: 38693707

2

Toward Predicting Nanoparticle Distribution in Heterogeneous Tumor Tissues.

MacMillan P, Syed AM, Kingston BR, Ngai J, Sindhwani S, Lin ZP, Nguyen LNM, Ngo W, Mladjenovic SM, Ji Q, Blackadar C, Chan WCW. MacMillan P, et al. Among authors: blackadar c. Nano Lett. 2023 Aug 9;23(15):7197-7205. doi: 10.1021/acs.nanolett.3c02186. Epub 2023 Jul 28. Nano Lett. 2023. PMID: 37506224

3

Biodistribution and toxicity of innate defense regulator 1018 (IDR-1018).

Esposito TVF, Rodríguez-Rodríguez C, Blackadar C, Haney EF, Pletzer D, Hancock REW, Saatchi K, Häfeli UO. Esposito TVF, et al. Among authors: blackadar c. Eur J Pharm Biopharm. 2022 Oct;179:11-25. doi: 10.1016/j.ejpb.2022.08.004. Epub 2022 Aug 24. Eur J Pharm Biopharm. 2022. PMID: 36028151

4

SPECT/CT Imaging of ¹¹¹Ag for the Preclinical Evaluation of Silver-Based Antimicrobial Nanomedicines.

Blackadar C, Choi KG, Embree MF, Hennkens HM, Rodríguez-Rodríguez C, Hancock REW, Saatchi K, Häfeli UO. Blackadar C, et al. ACS Appl Mater Interfaces. 2022 Jun 2. doi: 10.1021/acsami.2c03609. Online ahead of print. ACS Appl Mater Interfaces. 2022. PMID: 35653648

5

Why nanoparticles prefer liver macrophage cell uptake in vivo.

Ngo W, Ahmed S, Blackadar C, Bussin B, Ji Q, Mladjenovic SM, Sepahi Z, Chan WCW. Ngo W, et al. Among authors: blackadar c. Adv Drug Deliv Rev. 2022 Jun;185:114238. doi: 10.1016/j.addr.2022.114238. Epub 2022 Mar 31. Adv Drug Deliv Rev. 2022. PMID: 35367524 Review.

6

Preparation of Heat-Denatured Macroaggregated Albumin for Biomedical Applications Using a Microfluidics Platform.

Esposito TVF, Stütz H, Rodríguez-Rodríguez C, Bergamo M, Charles L, Geczy R, Blackadar C, Kutter JP, Saatchi K, Häfeli UO. Esposito TVF, et al. Among authors: blackadar c. ACS Biomater Sci Eng. 2021 Jun 14;7(6):2823-2834. doi: 10.1021/acsbiomaterials.1c00284. Epub 2021 Apr 7. ACS Biomater Sci Eng. 2021. PMID: 33826291

7

Historical review of the causes of cancer.

Blackadar CB. Blackadar CB. World J Clin Oncol. 2016 Feb 10;7(1):54-86. doi: 10.5306/wjco.v7.i1.54. World J Clin Oncol. 2016. PMID: 26862491 Free PMC article. Review.

8

Systematic review of hepatocellular carcinoma mortality rates among hepatitis B virus-infected renal transplant recipients, with supplemental analyses of liver failure and all-cause mortality.

Blackadar CB. Blackadar CB. Int J Infect Dis. 2013 Jan;17(1):e24-36. doi: 10.1016/j.ijid.2012.08.002. Epub 2012 Oct 1. Int J Infect Dis. 2013. PMID: 23036372 Free article. Review.

9

Re: Hepatocellular carcinoma and other liver diseases among Greenlanders chronically infected with hepatitis B virus: a population-based study.

Blackadar CB. Blackadar CB. J Natl Cancer Inst. 2012 Oct 3;104(19):1515-6; author reply 1516. doi: 10.1093/jnci/djs361. Epub 2012 Aug 23. J Natl Cancer Inst. 2012. PMID: 22923511 No abstract available.

10

A retrospective review of performance and utility of routine clinical pelvimetry.

Blackadar CS, Viera AJ. Blackadar CS, et al. Fam Med. 2004 Jul-Aug;36(7):505-7. Fam Med. 2004. PMID: 15243832 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page